Fujita Kazutoshi, Sugao Hideki, Gotoh Takayusu, Yokomizo Satoshi, Itoh Yasuhiro
Department of Urology Pathology, Minoh Municipal Hospital, Osaka, Japan.
Int J Urol. 2004 Mar;11(3):178-81. doi: 10.1111/j.1442-2042.2003.00763.x.
We report a case of primary signet ring cell carcinoma of the prostate in a 75-year-old man. Serum prostate specific antigen (PSA) level at presentation was 9.3 ng/mL. The tumor was confined within the right prostate lobe and the patient was treated with neoadjuvant hormonal therapy and radical prostatectomy. He was alive with no evidence of disease 12 months after surgery. None of the tumor was stained with periodic acid-Schiff and Alcian blue. Immunohistochemically, the tumor was positive for PSA and prostatic acid phosphatase and negative for carcinoembryonic antigen. We reviewed 41 previously reported cases of signet ring cell carcinoma of the prostate, examining both histopathological and clinical information.
我们报告一例75岁男性原发性前列腺印戒细胞癌。就诊时血清前列腺特异性抗原(PSA)水平为9.3 ng/mL。肿瘤局限于右前列腺叶,患者接受了新辅助激素治疗和根治性前列腺切除术。术后12个月他存活且无疾病证据。肿瘤组织经高碘酸-希夫染色和阿尔辛蓝染色均未着色。免疫组化显示,肿瘤组织前列腺特异性抗原和前列腺酸性磷酸酶呈阳性,癌胚抗原呈阴性。我们回顾了41例先前报道的前列腺印戒细胞癌病例,对组织病理学和临床信息进行了研究。